Medical Program: Breakthrough Breakdown: Impacts of Keynote-189

Breakthrough Breakdown: Impacts of Keynote-189

Breakthrough Breakdown: Impacts of Keynote-189
RestartResume
New data, new options? The clinical trial Keynote-189 might just set in motion a new era in NSCLC care.
  • Overview

    With profound results, Keynote-189 has led to change in the vast majority of U.S.-based oncologists, so now it's time to take a closer look.

    Dr. Shira Johnson welcomes Dr. Howard Jack West, who leads us on a deep dive into the clinical trial. From the study design to clinical implications, Dr. West highlights key findings, which may just unlock a new standard of care and better patient outcomes.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Facebook Comments

Sign up for the Global Oncology Academy newsletters.
Comprehensive Oncology Education.

Better education for a better you.

* Required
Optional

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free